MariMed Inc. (CSE:MRMD)
Market Cap | 57.20M |
Revenue (ttm) | 227.28M |
Net Income (ttm) | -17.50M |
Shares Out | n/a |
EPS (ttm) | -0.05 |
PE Ratio | n/a |
Forward PE | n/a |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 205,022 |
Average Volume | 23,619 |
Open | 0.1500 |
Previous Close | 0.1300 |
Day's Range | 0.1500 - 0.1650 |
52-Week Range | 0.0650 - 0.6000 |
Beta | 2.75 |
RSI | 60.39 |
Earnings Date | May 7, 2025 |
About MariMed
MariMed Inc. engages in cultivation, production, and selling of branded cannabis products in the United States and internationally. The company sells cannabis flower, vapes, and concentrates under the Nature’s Heritage brand; cannabis fruit chews that delivers better sleep, pain relief, stress relief, and others under Betty’s Eddies brand; and cannabis-infused ice creams under Emack & Bolio's brand. It offers soft and chewy baked goods and a hot chocolate mix under Bubby’s Baked brand; cannabis-infused hydrating drink mix for discrete and on-th... [Read more]
Financial Performance
In 2024, MariMed's revenue was $157.96 million, an increase of 6.30% compared to the previous year's $148.60 million. Losses were -$12.16 million, -24.12% less than in 2023.
Financial numbers in USD Financial StatementsNews
Cannabis Stock Gainers And Losers From April 14, 2025
GAINERS: Australis Capital (OTC: AUSAF) shares closed up 200.00% at $0.0003 Affinor Growers (OTC: RSSFF) shares closed up 51.26% at $0.05 CNBX Pharmaceuticals (OTC: CNBX) shares closed up 35.71% at...

MariMed Announces First Quarter 2025 Earnings Date
NORWOOD, Mass., April 08, 2025 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed” or “Company”) (CSE: MRMD) (OTCQX: MRMD), a leading cannabis consumer packaged goods company and retailer, announced today it ...

MariMed Promotes Ryan Crandall to Chief Commercial Officer
NORWOOD, Mass., April 07, 2025 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed” or “Company”) (CSE: MRMD) (OTCQX: MRMD), a leading cannabis consumer packaged goods company and retailer has promoted Ryan Cr...
Cannabis Stock Movers For April 3, 2025
GAINERS: Cann Group (OTC: CNGGF) shares closed up 217.50% at $0.02 1933 Industries (OTC: TGIFF) shares closed up 47.06% at $0.01 iAnthus Capital Hldgs (OTC: ITHUF) shares closed up 29.82% at $0.01 ...

MariMed's Betty's Eddies Expands Top-Selling Brand With Introduction of THC & CBG-Infused Caramel Chews
NORWOOD, Mass., April 03, 2025 (GLOBE NEWSWIRE) -- Betty's Eddies ™, the all-natural cannabis chews handcrafted to fit a variety of needs, is expanding its lineup with the introduction of delicious ca...

Know A Cannabis Leader Who Stands Out? Nominations Now Open For Bob Fireman Award By Benzinga
The Bob Fireman Award for Entrepreneurship will once again take center stage at the 2025 Benzinga Cannabis Capital Conference , which is taking place June 8-10 at the Chicago Marriott Downtown Magnifi...

MariMed Launches Nature's Heritage™ Flower in Illinois
NORWOOD, Mass., April 01, 2025 (GLOBE NEWSWIRE) -- MariMed Inc.
Marijuana Stock Movers For March 24, 2025
GAINERS: Affinor Growers (OTC: RSSFF) shares closed up 19.75% at $0.05 Blueberries Medical (OTC: BBRRF) shares closed up 16.25% at $0.01 CNBX Pharmaceuticals (OTC: CNBX) shares closed up 11.98% at ...

This Week In Cannabis: Snoop's Beverage Empire, Earnings, M&A, International News And More
The cannabis industry continues to evolve at breakneck speed and this past week was no exception. From significant financial transactions to regulatory shifts and high-profile business moves, the sect...

MariMed Inc. (MRMD) Q4 2024 Earnings Call Transcript
MariMed Inc. (OTCQX:MRMD) Q4 2024 - Earnings Conference Call March 6, 2025 8:00 AM ET Company Participants Sara Rosenfield - Brand Manager Jon Levine - CEO Ryan Crandall - Chief Revenue Officer Mario ...
MariMed Inc Reports Q4 2024 Earnings: EPS of -$0.02 Misses Estimate, Revenue of $39. ...
MariMed Inc Reports Q4 2024 Earnings: EPS of -$0.02 Misses Estimate, Revenue of $39.0 Million Below Expectations
MariMed GAAP EPS of -$0.02, revenue of $39M misses by $3M

MariMed Reports Fourth Quarter and Full Year 2024 Earnings
NORWOOD, Mass., March 05, 2025 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed” or the “Company”) (CSE: MRMD) (OTCQX: MRMD), a leading multi-state cannabis operator focused on improving lives every day, to...
MariMed Q4 2024 Earnings Preview

MariMed Completes Acquisition of First State Compassion, Strengthening Market Position in Delaware
NORWOOD, Mass., March 03, 2025 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed,” or the “Company”) (CSE: MRMD) (OTCQX: MRMD), a leading multi-state cannabis operator, announced today it has completed its a...
Cannabis Stock Movers For February 17, 2025
GAINERS: 1933 Industries (OTC: TGIFF) shares closed up 150.00% at $0.01 Leafbuyer Techs (OTC: LBUY) shares closed up 24.17% at $0.03 Global Hemp Group (OTC: GBHPF) shares closed up 15.38% at $0.03 ...

Cannabis Stock Valuations Reflect No Expectation Of Federal Reform: Study
A new valuation analysis by Viridian Capital Advisors suggests that U.S. multi-state cannabis operators (MSOs) are trading at levels that indicate no expectation of federal rescheduling or 280E tax re...

MariMed Announces Fourth Quarter and Full Year 2024 Earnings Date
NORWOOD, Mass., Feb. 11, 2025 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed” or the “Company”), (CSE: MRMD), (OTCQX: MRMD), a leading multi-state cannabis operator focused on improving lives every day, a...

MariMed Commences Wholesale Operations in Missouri
NORWOOD, Mass., Dec. 23, 2024 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed” or the “Company”) (CSE: MRMD) (OTCQX: MRMD), a leading multi-state cannabis operator, announces the launch of cannabis wholesa...

Is MariMed A Safe Haven In The Wake Of Florida's Cannabis Legalization Defeat?
Cannabis company MariMed Inc. (NASDAQ: MRMD) released its Q3 2024 results on November 6, announcing revised guidance for the fiscal year. While the company expects an 18–20% decline in EBITDA – down ...

Is MariMed A Safe Haven In The Wake Of Florida's Cannabis Legalization Defeat?
Cannabis company MariMed Inc. MRMD released its Q3 2024 results on November 6, announcing revised guidance for the fiscal year. While the company expects an 18–20% decline in EBITDA – down from its pr...
MariMed Inc (MRMD) Q3 2024 Earnings Call Highlights: Navigating Growth Amid Industry Challenges
MariMed Inc (MRMD) Q3 2024 Earnings Call Highlights: Navigating Growth Amid Industry Challenges
Q3 2024 MariMed Inc Earnings Call Transcript
Q3 2024 MariMed Inc Earnings Call Transcript

MariMed Inc. (MRMD) Q3 2024 Earnings Call Transcript
MariMed Inc. (OTCQX:MRMD) Q3 2024 Earnings Conference Call November 7, 2024 8:00 AM ET Company Participants Steve West - Vice President, Investor Relations Jon Levine - Chief Executive Officer Ryan Cr...

MariMed's Q3 Revenue Slightly Up YoY As Net Loss Improves, Revises Guidance
After the market closed Wednesday, multi-state cannabis operator MariMed Inc. (CSE: MRMD) (OTCQX: MRMD) reported its financial results for the third quarter ended Sep. 30, 2024. The Massachusetts-he...